Morgante G - Search Results

1

Effects of the selective estrogen receptor modulator, raloxifene, on carotid artery pulsatility index in postmenopausal women.

Setacci C, la Marca A, Agricola E, Morgante G, Setacci F, Cappelli A, Petraglia F, De Leo V. Setacci C, et al. Among authors: morgante g. Am J Obstet Gynecol. 2002 Apr;186(4):832-5. doi: 10.1067/mob.2002.122141. Am J Obstet Gynecol. 2002. PMID: 11967516 Clinical Trial.

2

Effects of raloxifene therapy on plasma renin and aldosterone levels and blood pressure in postmenopausal women.

Morgante G, Delia A, Musacchio MC, Severi FM, Petraglia F, De Leo V. Morgante G, et al. Gynecol Endocrinol. 2006 Jul;22(7):376-80. doi: 10.1080/09513590600850300. Gynecol Endocrinol. 2006. PMID: 16864147 Free article. Clinical Trial.

3

Resting ECG is modified after oophorectomy and regresses with estrogen replacement therapy in premenopausal women.

De Leo V, la Marca A, Agricola E, Morgante G, Mondillo S, Setacci C. De Leo V, et al. Among authors: morgante g. Maturitas. 2000 Jul 31;36(1):43-7. doi: 10.1016/s0378-5122(00)00123-7. Maturitas. 2000. PMID: 10989241 Clinical Trial.

4

Low-dose folic acid supplementation reduces plasma levels of the cardiovascular risk factor homocysteine in postmenopausal women.

De Leo V, La Marca A, Morgante G, Ciani F, Zammarchi E, Setacci C. De Leo V, et al. Among authors: morgante g. Am J Obstet Gynecol. 2000 Oct;183(4):945-7. doi: 10.1067/mob.2000.106345. Am J Obstet Gynecol. 2000. PMID: 11035344 Clinical Trial.

5

Randomized control study of the effects of raloxifene on serum lipids and homocysteine in older women.

De Leo V, la Marca A, Morgante G, Lanzetta D, Setacci C, Petraglia F. De Leo V, et al. Among authors: morgante g. Am J Obstet Gynecol. 2001 Feb;184(3):350-3. doi: 10.1067/mob.2001.111065. Am J Obstet Gynecol. 2001. PMID: 11228485 Clinical Trial.

6

Veralipride administered in combination with raloxifene decreases hot flushes and improves bone density in early postmenopausal women.

Morgante G, Farina M, Cianci A, La Marca A, Petraglia F, De Leo V. Morgante G, et al. Gynecol Endocrinol. 2004 Apr;18(4):194-8. doi: 10.1080/09513590410001692474. Gynecol Endocrinol. 2004. PMID: 15293890 Free article. Clinical Trial.

7

Human chorionic gonadotropin, thyroid function, and immunological indices in threatened abortion.

la Marca A, Morgante G, De Leo V. la Marca A, et al. Among authors: morgante g. Obstet Gynecol. 1998 Aug;92(2):206-11. doi: 10.1016/s0029-7844(98)00183-5. Obstet Gynecol. 1998. PMID: 9699752

8

The cardiovascular risk factor homocysteine is not elevated in young women with hyperandrogenism or hypoestrogenism.

Morgante G, La Marca A, Setacci F, Setacci C, Petraglia F, De Leo V. Morgante G, et al. Gynecol Obstet Invest. 2002;53(4):200-3. doi: 10.1159/000064561. Gynecol Obstet Invest. 2002. PMID: 12186983

9

Insulin-lowering treatment reduces aromatase activity in response to follicle-stimulating hormone in women with polycystic ovary syndrome.

la Marca A, Morgante G, Palumbo M, Cianci A, Petraglia F, De Leo V. la Marca A, et al. Among authors: morgante g. Fertil Steril. 2002 Dec;78(6):1234-9. doi: 10.1016/s0015-0282(02)04346-7. Fertil Steril. 2002. PMID: 12477517 Free article.

10

Menopause, the cardiovascular risk factor homocysteine, and the effects of treatment.

De Leo V, la Marca A, Morgante G, Musacchio MC, Luisi S, Petraglia F. De Leo V, et al. Among authors: morgante g. Treat Endocrinol. 2004;3(6):393-400. doi: 10.2165/00024677-200403060-00007. Treat Endocrinol. 2004. PMID: 15511133 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

118 results

Search Page

Filters